Qiagen NV is a NL-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Venlo, Limburg and currently employs 5,700 full-time employees. Qiagen NV is a holding company based in the Netherlands. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Qiagen NV hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü yıllık ödenmektedir ve son temettü hariç tarihi Jul 2, 2025 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$0.25
Jul 2, 2025
Ödeme Sıklığı
Ödeme Oranı
Yıllık
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Jul 2, 2025
$0.25
Jul 2, 2025
Jul 10, 2025
Jan 30, 2024
$1.3573
Jan 31, 2024
Feb 1, 2024
Dividend Grafikleri
QGEN Kâr Payları
QGEN Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
Qiagen NV'in şu anki temettü ödemesi ve yıllık temettüsü nedir?